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Abstract
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal failure, and studies have
supported a strong genetic influence on the risk of developing CKD. However, investigations of the underlying molecular
mechanisms are hampered by the lack of suitable hereditary models in animals. We therefore sought to establish hereditary
mouse models for CKD and renal fibrosis by investigating mice treated with the chemical mutagen N-ethyl-N-nitrosourea,
and identified a mouse with autosomal recessive renal failure, designated RENF. Three-week old RENF mice were smaller
than their littermates, whereas at birth they had been of similar size. RENF mice, at 4-weeks of age, had elevated
concentrations of plasma urea and creatinine, indicating renal failure, which was associated with small and irregularly
shaped kidneys. Genetic studies using DNA from 10 affected mice and 91 single nucleotide polymorphisms mapped the
Renf locus to a 5.8Mbp region on chromosome 17E1.3. DNA sequencing of the xanthine dehydrogenase (Xdh) gene revealed
a nonsense mutation at codon 26 that co-segregated with affected RENF mice. The Xdh mutation resulted in loss of hepatic
XDH and renal Cyclooxygenase-2 (COX-2) expression. XDH mutations in man cause xanthinuria with undetectable plasma
uric acid levels and three RENF mice had plasma uric acid levels below the limit of detection. Histological analysis of RENF
kidney sections revealed abnormal arrangement of glomeruli, intratubular casts, cellular infiltration in the interstitial space,
and interstitial fibrosis. TUNEL analysis of RENF kidney sections showed extensive apoptosis predominantly affecting the
tubules. Thus, we have established a mouse model for autosomal recessive early-onset renal failure due to a nonsense
mutation in Xdh that is a model for xanthinuria in man. This mouse model could help to increase our understanding of the
molecular mechanisms associated with renal fibrosis and the specific roles of XDH and uric acid.
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Introduction
Chronic kidney disease (CKD) is a major health problem
worldwide. Due to its progressive nature, patients with CKD are at
risk of developing cardiovascular disease and end stage renal
failure (ESRF), often in association with secondary hyperparathy-
roidism. Regardless of the initial cause, CKD and ESRF are
invariably associated with renal fibrosis, and often with glomer-
ulosclerosis, and immune activation, which leads to renal failure
[1]. The development of fibrosis within the kidney is a major factor
in renal impairment, although the mechanisms underlying this are
not fully understood and there are no effective treatments available
to retard or reverse its progression [1]. Population and genome-
wide association studies (GWAS) carried out in different ethnic
populations have suggested a genetic component in the suscepti-
bility to developing renal failure. For example, single nucleotide
polymorphisms (SNPs) within the myosin heavy chain type II
isoform A (MYH9)-Apolipoprotein L1 (APOL1) gene region were
found to be associated with ESRF in African Americans [2,3],
whilst several associations have been identified between SNPs and
CKD or markers of decreased renal function, such as SNPs near
genes involved in nephrogenesis, e.g. ALMS1, or solute transport,
e.g. SLC7A9, that were associated with CKD [4]. Furthermore,
some genes identified as associated with CKD in the general
population by GWAS, such as UMOD that encodes uromodulin,
can also cause monogenic renal disorders due to rare pathogenic
mutations [4,5]; thus both GWAS and studies of monogenic
inherited diseases can help to elucidate important biological
pathways. However, further investigations of the underlying
genetic and molecular mechanisms of CDK have been hampered
by the lack of suitable hereditary models in animals. To facilitate
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e45217
such studies, we embarked on establishing mouse models for renal
fibrosis and CKD by investigating the phenotypes of progeny of
mice treated with the chemical mutagen N-ethyl-N-nitrosourea
(ENU). ENU is a potent mutagen in mice, and as an alkylating
agent, introduces mainly point mutations into the genome [6].
Phenotype-driven screens of the offspring of ENU-mutagenised
mice are hypothesis-generating, and utilise a panel of morpholog-
ical, biochemical and other tests to identify phenotypes of interest
[6]. Since phenotype-driven screens do not make any assumptions
about the genetic cause of a phenotype, they may reveal novel
genes and pathways not previously associated with the phenotype.
ENU mutagenesis has generated a variety of mouse models,
including dominant and recessive, hypo- and hypermorphs, for
different diseases including renal disorders, such as Catweasel
mice, which are a model for branchio-oto-renal syndrome due to
a hypomorphic mutation in Six1 [7]. Here, we report studies of
one of the models which was identified during an ENU screen,
designated RENF (Renal Failure), which is a mouse model for
autosomal recessive early-onset renal failure.
Results
Phenotypic Identification of RENF Mice
The detection of abnormal renal function in G3 mice was based
on elevated plasma creatinine and urea concentrations, and/or
abnormal gross renal morphology. RENF mice, at 3 weeks of age,
were smaller (Figure 1A) and weighed ,23% less than their
unaffected littermates (10.7260.33g for unaffected mice versus
8.2760.31g for affected mice, p,0.001) (Figure 1B), whereas at
birth, RENF mice and their unaffected littermates had been of the
same size. They failed to thrive and did not live beyond 5–9 weeks
of age. Post mortem analysis undertaken at 4 weeks of age revealed
that kidneys from RENF mice were smaller, irregularly shaped
and had a fatty appearance when compared to kidneys from
unaffected littermates (Figure 1C). The anatomy of other internal
organs appeared normal (Figure 1D). Inheritance testing could not
be undertaken through mating of the mutant mice because they
died before puberty. However, random intercrossing of unaffected
male and female littermates resulted in progeny in which ,25%
had the RENF phenotype, consistent with autosomal recessive
inheritance.
Abnormal Plasma Biochemical Profile in RENF Mice
Biochemical analysis of plasma at 4 weeks of age revealed male
RENF mice to have elevated levels of several biochemical
parameters, when compared to unaffected mice. Thus, RENF
mice had significantly elevated concentrations of urea and
creatinine (p,0.005) (Table 1), indicating renal failure. Moreover,
two RENF mice had elevated plasma urea concentrations that
were above the upper limit of detection and could not be included
in the analysis. In addition, RENF mice had increased concentra-
tions of calcium (corrected for albumin) (p,0.01) and increased
alkaline phosphatase activity (p,0.05) (Table 1), consistent with
tertiary hyperparathyroidism in RENF mice.
Mapping of the Renf Locus to Chromosome 17E1.3 and
Identification of a Xdh Nonsense Mutation
Genome-wide analysis using 91 SNPs and DNA from 10
affected and 14 unaffected mice mapped the Renf locus to a 5.8Mb
region on chromosome 17 flanked by the SNPs rs3657117 and
rs33373680 (Figure 2A). This interval contained 40 genes
(Table 2), of which 23 have been reported to be expressed in
the kidney. Among these 23 genes, only xanthine dehydrogenase
(Xdh) is known to cause autosomal recessive renal failure in man
due to loss of function mutations [8–12]. Mutational analysis of the
Xdh gene was therefore undertaken in RENF mice by DNA
sequencing, which revealed a homozygous G.T transversion
causing a nonsense mutation at codon 26, Glu26Stop (E26X)
(Figure 2B). This mutation resulted in a gain of an MseI restriction
endonuclease recognition site in exon 2 of Xdh (Figure 2B,C),
which was utilised for genotyping of unaffected and affected
RENF mice. All affected mice were homozygous for the E26X
mutation (Figure 2D). Re-analysis of the weights of unaffected
mice showed no difference between the weights of wild-type and
heterozygous mice at weaning (data not shown). The Xdh gene
encodes the enzyme, XDH, that catalyses the predominantly
hepatic oxidative conversion of xanthine and hypoxanthine to uric
acid in the purine catabolic pathway. Immunohistochemical
analysis of hepatic sections from RENF mice and wild-type
littermates revealed that the Xdh E26X mutation in the RENF
mice resulted in loss of hepatic XDH expression (Figure 2E).
Mouse Xdh consists of 36 exons, which encode 1335 amino acids
with 89% identity and 95% similarity with the human XDH
protein. Loss-of-function mutations of XDH in man cause
hereditary xanthinuria, which is characterised by very low or
undetectable plasma uric acid levels [8–12]. We therefore
measured plasma uric acid levels in a subset of unaffected and
affected RENF mice, and found that in 3 out of 3 RENF mice, the
uric acid concentration was below the limit of detection for the
assay, compared to concentrations of 72 mmol/l, 107 mmol/l and
116 mmol/l in 3 unaffected mice.
Gross Morphological and Cellular Lesions in RENF
Kidneys
Histological analysis of kidney sections using H&E staining
confirmed the smaller size of kidneys from RENF mice and also
revealed an irregular shape of the outer kidney capsule in RENF
mice, when compared to kidneys from unaffected littermates
(Figure 3A). There was an altered distribution of glomeruli within
the kidneys of RENF mice compared to wild-type littermates, thus
in wild-type mice, glomeruli were distributed around the renal
cortex, but in RENF mice, there was a high density of glomeruli in
some regions, with other regions being almost devoid of glomeruli
and having only tubules (Figure 3B). The areas of dense glomeruli
corresponded to dips in the outer capsule, and the areas of tubules
corresponded to bulges in the outer capsule (Figure 3A,B). There
was extensive tubular cell damage with detachment of cells within
dilated tubules, and accumulation of eosinophilic amorphous
intraluminal casts in kidneys from RENF mice, in some cases
filling the cross-sectional area of the dilated tubule (Figure 3C),
and some damaged tubules were detached from the basement
membrane. There was also extensive lymphocytic infiltration in
RENF kidneys (Figure 3B,C), which was absent in wild-type
kidneys. The intratubular aggregates were periodic-acid Schiff
(PAS)-positive and some were surrounded by nuclei. PAS staining
also revealed thickening and shrinkage of the tubular basement
membrane (Figure 3D). Staining of RENF and normal kidney
sections with von Kossa was negative for calcium mineralization
and Congo red staining did not reveal any deposition of amyloid in
RENF mice (data not shown). Staining using Masson’s trichrome
revealed a disorganized pattern of collagen and reticular fibres in
kidneys from RENF mice compared to unaffected kidneys
(Figure 3E), indicating the presence of interstitial fibrosis. TUNEL
analysis of kidney sections revealed extensive apoptosis of tubular
epithelial cells in RENF mice when compared to unaffected
littermates (Figure 3F). Cyclooxygenase-2 (COX-2) expression,
which is required for post-natal renal development and has
previously been shown to be lost in mice deficient for xanthine
Mouse with Xanthine Dehydrogenase Mutation
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oxidoreductase (Xor2/2) [13], was found to be virtually absent in
kidney sections of RENF mice when compared to those from
unaffected littermates, in whom COX-2 expression was detected
in a subset of tubules predominantly in the corticomedullary
region (Figure 3G).
Discussion
In this study we describe an ENU-induced mouse mutant
named RENF, presenting with clinical features of failure to thrive,
early onset renal failure and interstitial nephritis, due to a Xdh
nonsense mutation which is located within the iron-sulphur (2Fe-
2S) ferredoxin-type domain close to the N-terminus of XDH
(Table 1, Figures 1–3). This E26X mutation (Figure 2B, C and D)
was induced by ENU, which is known to induce multiple
mutations simultaneously [14]. However, the likelihood that
another genetic defect within the 5.8Mbp region that was
established to be the location of the Renf locus (Figure 2A), could
be the underlying cause of RENF is ,0.005, based on the
following reasoning. The nominal ENU-induced base pair
mutation rate for potentially functional mutations has been
estimated to be 1 in 1.82Mbp of coding DNA in the F1 founder
animals [15], and given that ,2.5% of the mouse genome is
coding, it has been calculated that the probability of two functional
mutations arising within a 5Mb genomic region is ,0.002 [16];
thus, the likelihood of the Xdh E26X mutation and another
functional mutation arising within the 5.8Mbp containing the
RENF locus is ,0.0023. This indicates that the Xdh E26X
mutation, which was shown to be associated with loss of hepatic
XDH (Figure 2E) and renal COX-2 expression (Figure 3G), is
highly likely to be the sole genetic defect causing RENF.
RENF mice have phenotypic characteristics that are similar to
those reported for the Xor2/2 mouse, including early mortality,
renal failure, interstitial nephritis with intratubular deposits, and
undetectable plasma uric acid (Table 3). These similarities
between the RENF and Xor2/2 mice are consistent with the loss
of expression of XDH (Figure 2E) and COX-2 (Figure 3G) in both
mouse models. However, RENF mice had extensive apoptosis of
tubular cells (Figure 3F), and elevated plasma calcium and ALP
(Table 1), consistent with tertiary hyperparathyroidism, as well as
elevated plasma creatinine concentrations, which were not
reported in the Xor2/2 mice [13], whereas Xor2/2 mice had
renal cysts (Table 3), which were not detected in RENF mice. The
basis of these differences between the RENF mice and Xor2/2
mice remains to be elucidated. A possible explanation may involve
strain-specific differences, as the Xor2/2 mice were on a mixed
129/Sv–C57BL/6J background [13], whilst the RENF mice were
on a C3H–C57BL/6J mixed background. In addition, ENU-
induced mouse models have been reported to differ in phenotypic
features when compared to the corresponding null mice, generated
using targeted gene ablation strategies [14]. For example, mice
with a hypomorphic ENU mutation in the forkhead transcription
factor Foxc1 have been reported to have phenotypic differences
when compared to mice deficient for Foxc1; thus, the ENU
hypomorphic mice, unlike the Foxc1 deficient mice, did not die in
utero, thereby facilitating the study of previously uncharacterised
roles for FOXC1. In addition, the ENU hypomorphic Foxc1 mice,
when compared to Foxc1 deficient mice, had greater similarity to
patients with Axenfeld-Rieger syndrome (ARS) that is due to Foxc1
mutations [17]. These differences between the ENU-induced
RENF and Xor2/2 mouse models highlight the advantages of
having two allelic variants that provide the opportunity of
elucidating further the relationships between the phenotype and
the likely protein structure and its in vivo function [18].
Mutations in XDH in man give rise to classical xanthinuria type
I, a rare genetic disorder characterised by elevated serum and
urinary concentration of xanthine and renal xanthine calculi, in
association with undetectable levels of uric acid [8–12]. Mutations
detected in man have included nonsense mutations at codons 228
and 722 [8,11], frameshifting insertions and deletions [8,9,12],
and missense mutations [10,12]. One patient with a nonsense
mutation (R228X) was found to have an absence of XDH protein
[8], whilst assays of XDH activity in duodenal mucosa biopsy
samples from patients with a frameshift insertion at codon 569 and
a missense mutation (R149C) showed ,5% and undetectable
XDH activities, respectively [9,10]. Thus, these genetic defects are
likely to result in a loss of XDH activity similar to that in Xor2/2
and RENF mice (Figure 2E). However, a major difference
between xanthinuria in man and the phenotype of both the
Xor2/2 and RENF mice is the striking renal phenotype in the
mouse models, which leads to premature death within several
weeks (Table 2). In contrast, patients with xanthinuria do not
always progress to renal failure, and some remain asymptomatic
[9]. This difference between mouse and man is likely due to post-
natal renal development in mice, which does not occur in man. In
man, nephrogenesis and glomerulogenesis are completed before
birth [19]; however murine post-natal renal development is
dependent on induction of COX-2 expression, which is absent
in Xor2/2 and RENF mice (Figure 3G), although it is not clear
whether induction of COX-2 expression is due to uric acid or to
another function of XDH [13]. The role of XDH and COX-2 in
post-natal renal development in mice is consistent with the lack of
any distinguishable abnormalities in the RENF mice at birth and
in the Xor2/2 or Cox-2 null mice before 1 week of age [13,20];
furthermore, the kidneys of Cox-2 null mice at ages 3 and 7 days
Figure 1. Gross anatomical features of RENF mice. (A) Whole-body X-ray of 3-week old mice revealing small size of RENF mice. (B) Weights of 3-
week old mice revealing reduced weight of RENF mice, when compared to unaffected littermates (* = p,0.001). (C) Anatomical appearance of
kidneys from 4-week old mice revealing smaller, irregularly shaped and fatty kidneys from a RENF mouse compared to an unaffected littermate. (D)
Histological appearance of other organs stained by H&E from 4-week old mice, revealing normal anatomy in unaffected and affected RENF mice.
Scale bars: 200mm for heart and lung; 50mm for liver, spleen, pancreas and intestine.
doi:10.1371/journal.pone.0045217.g001
Table 1. Plasma biochemical analysis of 4-week old male
mice.
Unaffected (n =4) RENF (n =5) P-valuea
Creatinine (mmol/l) 42.33611.86 187.26618.72 ,0.005
Urea (mmol/l) 10.1862.50 80.90611.82b ,0.005
Corr.Ca (mmol/l) 2.6560.06 3.1360.10 ,0.01
Phosphorous (mmol/l) 4.0060.66 6.5160.92 = 0.07
ALP (U/l) 236.50692.00 682.406137.84 ,0.05
Corr.Ca: calcium concentration corrected for albumin, derived from the
equation Corr.Ca =Ca (mmol/l)2((Alb(g/l)230)60.017); ALP: alkaline
phosphatase.
ap-values calculated using Student’s unpaired, two-tailed t-test.
bn = 3 as two samples had a urea concentration greater than the upper limit of
the assay.
doi:10.1371/journal.pone.0045217.t001
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Figure 2. Mapping and identification of the gene mutation causing RENF. (A) The RENF locus was mapped to a 5.8Mbp interval flanked by
the SNPs rs3657117 and rs33373680 on chromosome 17, which contained 40 genes. (B) DNA sequence analysis of the Xdh gene revealed
Mouse with Xanthine Dehydrogenase Mutation
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a homozygous G.T transversion in exon 2, changing codon 26 from GAA to TAA, resulting in a nonsense mutation. (C) The Glu26Stop mutation also
generated a MseI restriction endonuclease recognition site, thus cleavage of a 209 bp PCR product by MseI yielded 115bp and 94bp fragments in
mutant alleles but did not cut wild-type alleles. (D) MseI digest was used to genotype unaffected and affected RENF mice. All affected RENF mice
were homozygous for the Glu26Stop mutation. (E) Immunohistochemistry showed loss of hepatic XDH expression in RENF mice compared to
unaffected littermates. Scale bars = 200 mm.
doi:10.1371/journal.pone.0045217.g002
Table 2. Genes within the 5.8Mbp interval containing the Renf locus on Chromosome 17, and their level of renal expression.
Gene name (symbol) Renal expression
Erythrocyte protein band 4.1-like 3 (Epb4.1l3) ++
Zinc finger protein 161 (Zfp161) +
RIKEN cDNA C030034I22 gene (C030034I22Rik) –
RIKEN cDNA A330050F15 gene (A330050F15Rik) –
Discs, large (Drosophila) homolog-associated protein 1 (Dlgap1) –
TGFB-induced factor homeobox 1 (Tgif1) +
Myosin, light chain 12B, regulatory (Myl12b) –
Myosin, light chain 12A, regulatory, non-sarcomeric (Myl12a) +
Myomesin 1 (Myom1) –
Lipin 2 (Lpin2) +
Elastin microfibril interface 2 (Emilin2) –
SMC hinge-domain containing 1 (Smchd1) +
NDC80 homolog, kinetochore complex component (S. cerevisiae) (Ndc80) –
Methyltransferase like 4, pseudogene 1 (Mettl4-ps1) –
Speedy homolog A (Xenopus laevis) (Spdya) –
tRNA methyltransferase 61 homolog B (S. cerevisiae) (Trmt61b) +
WD repeat domain 43 (Wdr43) ++
Small nucleolar RNA, C/D box 92 (Snord92) NK
Small nucleolar RNA, C/D box 53 (Snord53) NK
Family with sequence similarity 179, member A (Fam179a) –
cDNA sequence BC027072 (BC027072) –
CAP-GLY domain containing linker protein family, member 4 (Clip4) +
Anaplastic lymphoma kinase (Alk) –
Yippee-like 5 (Drosophila) (Ypel5) ++
Limb-bud and heart (Lbh) +
Lysocardiolipin acyltransferase 1 (Lclat1) ++
Calpain 13 (Capn13) –
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (Galnt14) +
EH-domain containing 3 (Ehd3) +
Xanthine dehydrogenase (Xdh) ++
Steroid 5 alpha-reductase 2 (Srd5a2) +
Mediator of cell motility 1 (Memo1) +
Dpy-30 homolog (C. elegans) (Dpy30) ++
Spastin (Spast) +
Solute carrier family 30 (zinc transporter), member 6 (Slc30a6) ++
NLR family, CARD domain containing 4 (Nlrc4) NK
Ribosomal protein S6 pseudogene (Gm6476) +
Yip1 domain family, member 4 NK
Baculoviral IAP repeat-containing 6 (Birc6) +
Tetratricopeptide repeat domain 27 (Ttc27) +
TGFB: transforming growth factor-b; SMC: structural maintenance of chromosomes; CAP-GLY: cytoskeleton-associated proteins-glycine rich; EH: Eps15 homology; NLR:
Nod-like receptor; CARD: caspase activation and recruitment domain; IAP: inhibitor of apoptosis. – no expression; + weak expression; ++ moderate expression. NK: not
known. Expression data obtained from BioGPS [32].
doi:10.1371/journal.pone.0045217.t002
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have also been reported to be normal [20]. Indeed, the altered
distribution of glomeruli in RENF mice (Figure 3B) is suggestive of
a developmental defect, and is reminiscent of a similar phenotype
described in Cox-2 null mice, in which glomeruli were clustered in
the subcapsular region [20]. In man, renal development is
completed before birth, and during gestation, the abnormal
purine metabolism in the foetus is likely to be compensated for by
maternal XDH, since uric acid, xanthine and hypoxanthine can
cross the placental membrane. Whilst the renal symptoms in
xanthinuria patients can be attributed directly to the elevated
levels of xanthine in the kidney, it is unclear whether the absence
of plasma uric acid has any additional detrimental effect. In Xor2/
2 and RENF mice, the developing foetus can also benefit from
maternal XDH activity; however plasma uric acid levels will
decrease rapidly in the immediate post-natal period, since the
expression of uricase in mice, which is evolutionarily silenced in
man, will metabolise any plasma uric acid to allantoin [21]. In
contrast, in man, more than 90% of filtered uric acid is reabsorbed
by the kidney and not metabolised [21], thus plasma uric acid
levels may be maintained for longer after birth, thus any effect of
lack of uric acid on the phenotype may be magnified in mice
compared to man. Studies of models such as Xor2/2 and RENF
may help to clarify the relative roles of elevated xanthine and lack
of uric acid, in the pathogenesis of xanthinuria, for example by the
use of uricase inhibitors to maintain plasma uric acid levels after
birth.
Widespread fibrosis, large intratubular deposits, and extensive
apoptosis of tubular epithelial cells were observed in kidneys of
RENF mice (Figure 3D, E and F). Apoptosis of tubular cells may
be caused by mechanical stress as a result of intratubular deposits
[22]. However, the mechanism by which apoptotic cells may
trigger a cascade of pro-fibrotic events is not clear, but may involve
uric acid, which is released by apoptotic cells, and acts as a ‘danger’
signal to stimulate immune cells [23]. Thus, a local high
concentration of uric acid may stimulate resident interstitial
immune cells, which could then initiate the fibrotic cascade, an
effect that may be more potent in the context of the otherwise low
systemic concentration of uric acid in the RENF mice. The
absence of expression of COX-2 in the RENF mice (Figure 3G)
may further contribute to the renal fibrosis as follows. Fibrosis is
observed in the Cox-2 null mice [20], and this likely involves its
main substrate, arachidonic acid, which can also be metabolised
by 5-lipoxygenase (5-LOX) to generate leukotrienes that are able
to stimulate inflammatory processes [24]. Thus, in the absence or
reduction of COX-2, the flux through the 5-LOX pathway may
be increased, as reported by studies of lungs from Cox-2 null mice
that had an increased inflammatory response to an allergy
challenge compared to wild-type mice [25], and by administration
of Cox inhibitor in rats that led to an increase in levels of the
leukotriene LTB4 [24]. These observations suggest that the
absence of COX-2 expression in RENF kidneys (Figure 3G)
may also propagate any damage that is initiated by the
intratubular deposits, by causing inflammation and triggering
a fibrotic cascade.
In summary, our studies have established a novel mouse model
for Xdh deficiency, due to an ENU-induced nonsense mutation,
that is associated with early onset renal failure and fibrosis. Our
studies demonstrate that ENU mutagenesis may be useful for
generation of mouse models for renal failure, and that this RENF
model may help to elucidate further mechanisms of renal fibrosis
and the in vivo role of XDH and uric acid.
Materials and Methods
Ethics Statement
All animal studies were carried out using guidelines issued by
the Medical Research Council in ‘Responsibility in the Use of
Animals for Medical Research’ (July 1993) and Home Office
Project License Number 30/2433. Experiments were approved by
the Medical Research Council Harwell ethics committee, and all
efforts were made to minimize suffering.
Generation of Mutant Mice
Male C57BL/6J mice were treated with ENU and mated with
untreated C3H female mice [14]. The male progeny (G1) were
subsequently mated with normal C3H females to generate G2
progeny. The female G2 progeny were backcrossed to their G1
fathers and the resulting G3 progeny were screened for recessive
phenotypes [18]. Mice were fed an expanded rat and mouse no. 3
breeding diet (Special Diets Services, Witham, UK) containing
Figure 3. Histological analysis of kidney sections from 4 week old RENF and unaffected mice. (A–C) H&E staining showing: (A) small size
and grossly abnormal morphology of RENF kidneys (scale = 5mm); (B) condensed renal cortex with some areas containing a high density of glomeruli
in RENF kidneys compared to even distribution of glomeruli and tubules in unaffected kidneys (scale = 250mm); and (C), luminal casts within dilated
tubules that are detached from the basement membrane in RENF kidneys (scale = 100mm). (D) Periodic-acid Schiff (PAS) staining showing PAS-
positive intraluminal casts surrounded by nuclei, and thickened basement membranes in RENF kidneys (scale = 100mm). (E) Masson’s trichrome
staining showing the presence of fibrosis in RENF mice (blue) when compared to unaffected littermates (scale = 100mm). (F) TUNEL staining showing
apoptosis of tubular epithelial cells in kidneys from RENF mice, which was not detected in kidneys from unaffected littermates (scale = 100mm). (G)
Immunohistochemical analysis of COX-2 expression showed loss of COX-2 expression in affected RENF mice compared to unaffected littermates
(scale = 50mm).
doi:10.1371/journal.pone.0045217.g003
Table 3. Comparison of XOR2/2 and RENF mouse models.
Characteristic XOR2/2 micea RENF mice
Derivation of mutation Gene disruption ENU
Nature of mutation KO Nonsense
Renal failure + +
Early death + +
Plasma urea q q
Plasma creatinine Normal q
Plasma corrected calcium NR q
Plasma ALP NR q
Plasma uric acid Below detection limitUndetectable
Renal cysts + –
Deposits in renal tubules + +
Inflammatory infiltration + +
Renal interstitial fibrosis + +
Renal tubular apoptosis NR q
+, present; –, absent; q, increased; Q, decreased; NR, not reported; ND, not
determined; ALP, alkaline phosphatase; COX-2, cyclooxygenase-2; KO, knock-
out; ENU, N-ethyl-N-nitrosourea.
aData for xanthine oxidoreductase null (XOR2/2) mice from Ohtsubo et al. 2004
[13] and Ohtsubo et al. 2009 [33].
doi:10.1371/journal.pone.0045217.t003
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1.15% calcium, 0.82% phosphorus and 4088.65 units/kg vitamin
D, and given water ad libitum.
Dysmorphology and Biochemical Screening
A simple dysmorphology screen based on observation and
weighing of mice to look for any gross anatomical changes was
used to monitor all mice as previously described [26]. Blood
samples were collected from the retro-orbital sinus after terminal
anaesthesia, and plasma was separated by centrifugation at
30006g for 5 min at 4uC, and analysed for urea, creatinine, total
calcium, inorganic phosphate, alkaline phosphatase, albumin and
uric acid, on a Beckman Coulter AU680 semi-automated clinical
chemistry analyzer using reagents and protocols provided by the
manufacturer. Plasma calcium was corrected for albumin
(Corr.Ca) using the formula: Corr.Ca=Ca (mmol/l)2((Alb(g/
l)230)60.017) [27]. P-values were determined using Student’s
unpaired, two tailed t-test. Skeletons of mice fixed in 10% formalin
after terminal anaesthesia were subjected to digital radiography at
26kV for 3 seconds using a Faxitron MX-20 digital X-ray system
(Faxitron X-ray Corporation, Lincolnshire, USA) [28].
Mapping, DNA Sequencing and Genotyping
Genomic DNA was extracted from tail or auricular biopsies as
described [29]. For genome-wide mapping, genomic DNA was
amplified by PCR using a panel of 91 single nucleotide poly-
morphism (SNP) markers arranged in chromosome sets, and the
products were analysed by pyrosequencing [30]. Individual exons
and intron-exon boundaries of the Xdh gene were amplified from
genomic DNA by PCR using gene-specific primers and Taq PCR
Mastermix (Qiagen), and the PCR products sequenced using
BigDye terminator reagents and ABI 3100 sequencer (Life
Technologies, Carlsbad, USA) [31]. For genotyping, DNA was
amplified by PCR using primers specific for exon 2 of Xdh, and
PCR products were subject to restriction endonuclease digest
using MseI (New England Biolabs). Digested products were
analysed by agarose gel electrophoresis and images captured
using a ChemiDoc XRS+ and Image Lab software (BioRad).
Histological and Immunohistochemical Analysis
Dissected tissues were fixed in formalin, processed and
embedded in paraffin blocks for histological and immunohisto-
chemical analysis. Sections (3–4 mm) were stained with haematox-
ylin and eosin (H&E), von Kossa, periodic-acid Schiff, Masson’s
trichrome and Congo red. For immunohistochemistry to detect
XDH and COX-2 expression, sections were subject to heat-
induced epitope retrieval in citrate buffer (pH6.0), followed by
blocking in 10% goat or donkey serum, respectively, and
incubation in rabbit anti-XDH (C-terminus) antibody (Santa
Cruz, 1:50) or goat anti-COX-2 antibody (Santa Cruz, 1:200),
respectively, at room temperature for 1 hour, and probed using the
Envision+ (rabbit) kit (Dako) or donkey anti-goat horseradish
peroxidase conjugated antibody (Jackson) and the Vector DAB kit,
respectively. Nuclei were counterstained with haematoxylin.
Stained sections were scanned and digital images captured using
a Nanozoomer 2.0 virtual microscope (Hamamatsu Corporation,
Japan). TUNEL staining was performed on sections using the
ApopTag Fluorescein In Situ Apoptosis Detection kit (Millipore).
Stained sections were mounted in VECTASHIELDH mounting
medium containing DAPI (Vector laboratories, Peterborough,
UK) to detect nuclei.
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